These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22591360)

  • 21. Progress in understanding basal ganglia dysfunction as a common target for methamphetamine abuse and HIV-1 neurodegeneration.
    Theodore S; Cass WA; Nath A; Maragos WF
    Curr HIV Res; 2007 May; 5(3):301-13. PubMed ID: 17504172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. If a US drug abuse epidemic fails to include a major east coast city, can it be called an epidemic?
    Rawson RA; Simon SL; Ling W
    J Addict Dis; 2002; 21(1):1-4. PubMed ID: 11831495
    [No Abstract]   [Full Text] [Related]  

  • 23. Amphetamine usage and genital self-mutilation.
    Israel JA; Lee K
    Addiction; 2002 Sep; 97(9):1215-8. PubMed ID: 12199837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystallizing the HIV epidemic: methamphetamine, unsafe sex, and gay diseases of the will.
    Worth H; Rawstorne P
    Arch Sex Behav; 2005 Oct; 34(5):483-6. PubMed ID: 16211470
    [No Abstract]   [Full Text] [Related]  

  • 25. NeuroAIDS in Brazil.
    Ellis RJ; Joseph J; de Almeida SM
    J Neurovirol; 2007 Apr; 13(2):89-96. PubMed ID: 17505977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence-Based Guidelines for the Pharmacological Management of Acute Methamphetamine-Related Disorders and Toxicity.
    Wodarz N; Krampe-Scheidler A; Christ M; Fleischmann H; Looser W; Schoett K; Vilsmeier F; Bothe L; Schaefer C; Gouzoulis-Mayfrank E
    Pharmacopsychiatry; 2017 May; 50(3):87-95. PubMed ID: 28297728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preface. Emerging targets and therapeutics in the treatment of psychostimulant abuse.
    Dwoskin LP
    Adv Pharmacol; 2014; 69():xi-xiii. PubMed ID: 24484989
    [No Abstract]   [Full Text] [Related]  

  • 28. Bath salts and polyconsumption: in search of drug-drug interactions.
    Lopez-Rodriguez AB; Viveros MP
    Psychopharmacology (Berl); 2019 Mar; 236(3):1001-1014. PubMed ID: 30911791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of methamphetamine abuse and their consequences.
    Cho AK; Melega WP
    J Addict Dis; 2002; 21(1):21-34. PubMed ID: 11831497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preintervention Profiles of Information, Motivational, and Behavioral Self-Efficacy for Methamphetamine Use and HIV Medication Adherence Among Gay and Bisexual Men.
    Starks TJ; Millar BM; Lassiter JM; Parsons JT
    AIDS Patient Care STDS; 2017 Feb; 31(2):78-86. PubMed ID: 28092450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulant Use Disorders.
    Park TM; Haning WF
    Child Adolesc Psychiatr Clin N Am; 2016 Jul; 25(3):461-71. PubMed ID: 27338967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TCA cycle metabolic compromise due to an aberrant S-nitrosoproteome in HIV-associated neurocognitive disorder with methamphetamine use.
    Doulias PT; Nakamura T; Scott H; McKercher SR; Sultan A; Deal A; Albertolle M; Ischiropoulos H; Lipton SA
    J Neurovirol; 2021 Jun; 27(3):367-378. PubMed ID: 33876414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experiences and sexual behaviors of HIV-infected MSM who acquired HIV in the context of crystal methamphetamine use.
    Mimiaga MJ; Fair AD; Mayer KH; Koenen K; Gortmaker S; Tetu AM; Hobson J; Safren SA
    AIDS Educ Prev; 2008 Feb; 20(1):30-41. PubMed ID: 18312065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical effects and management of methamphetamine abuse.
    Romanelli F; Smith KM
    Pharmacotherapy; 2006 Aug; 26(8):1148-56. PubMed ID: 16863490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcortical hemorrhage caused by methamphetamine abuse: efficacy of the triage system in the differential diagnosis--case report.
    Inamasu J; Nakamura Y; Saito R; Kuroshima Y; Mayanagi K; Ohba S; Ichikizaki K
    Neurol Med Chir (Tokyo); 2003 Feb; 43(2):82-4. PubMed ID: 12627885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prenatal exposure to metamphetamine «shabu»].
    Manzano Varo C; López-Vílchez MÁ; Román Eyo L; García García J; Mur Sierra A
    An Pediatr (Barc); 2017 Feb; 86(2):96-97. PubMed ID: 27346796
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk and protective factors for methamphetamine use and nonmedical use of prescription stimulants among young adults aged 18 to 25.
    Herman-Stahl MA; Krebs CP; Kroutil LA; Heller DC
    Addict Behav; 2007 May; 32(5):1003-15. PubMed ID: 16920275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection.
    Carrico AW; Cherenack EM; Roach ME; Riley ED; Oni O; Dilworth SE; Shoptaw S; Hunt P; Roy S; Pallikkuth S; Pahwa S
    AIDS; 2018 Mar; 32(6):767-771. PubMed ID: 29369159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.
    Sutter ME; Gaedigk A; Albertson TE; Southard J; Owen KP; Mills LD; Diercks DB
    Clin Toxicol (Phila); 2013 Aug; 51(7):540-4. PubMed ID: 23855716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Why do we need an Addiction supplement focused on methamphetamine?
    Rawson RA; Condon TP
    Addiction; 2007 Apr; 102 Suppl 1():1-4. PubMed ID: 17493048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.